{"nctId":"NCT04659863","briefTitle":"Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia","startDateStruct":{"date":"2021-02-16","type":"ACTUAL"},"conditions":["Familial Hypercholesterolemia - Homozygous"],"count":13,"armGroups":[{"label":"Part 1 - Inclisiran","type":"EXPERIMENTAL","interventionNames":["Drug: Inclisiran"]},{"label":"Part 1 - Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Part 2 - Inclisiran (Total)","type":"EXPERIMENTAL","interventionNames":["Drug: Inclisiran"]}],"interventions":[{"name":"Inclisiran","otherNames":["KJX839"]},{"name":"Placebo","otherNames":["Saline solution"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Homozygous Familial Hypercholesterolemia (HoFH) diagnosed by genetic confirmation\n* Fasting LDL-C \\>130 mg/dL (3.4 mmol/L) at screening\n* On maximally tolerated dose of statin (investigator's discretion) with or without other lipid-lowering therapy; stable for â‰¥ 30 days before screening\n* Male or female participants \\>=12 to \\<18 years of age at screening\n\nExclusion Criteria:\n\n* Documented evidence of a null (negative) mutation in both LDLR alleles\n* Heterozygous familial hypercholesterolemia (HeFH)\n* Active liver disease\n* Secondary hypercholesterolemia, e.g. hypothyroidism or nephrotic syndrome\n* Previous treatment with monoclonal antibodies directed towards PCSK9 (within 90 days of screening)\n* Treatment with mipomersen or lomitapide (within 5 months of screening)\n* Recent and/or planned use of other investigational medicinal products or devices","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Years","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage Change in LDL-C From Baseline to Day 330 (Part 1/Year 1)","description":"Percentage change in low-density lipoprotein cholesterol (LDL-C) from baseline to Day 330 (Year 1)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-21.6","spread":"13.36"},{"groupId":"OG001","value":"11.7","spread":"30.52"}]}]}]},{"type":"SECONDARY","title":"Time-adjusted Percent Change in LDL-C From Baseline After Day 90 and up to Day 330 (Part 1/Year 1)","description":"Time-adjusted percent change in LDL-C (after Day 90 and up to Day 330), calculated as the average of percent changes from baseline to Days 150, 270 and 330","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-21.0","spread":"15.11"},{"groupId":"OG001","value":"13.0","spread":"41.88"}]}]}]},{"type":"SECONDARY","title":"Percent Change in LDL-C From Baseline up to Day 720","description":"Percentage change in LDL-C from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-26.1","spread":"13.53"},{"groupId":"OG001","value":"6.8","spread":"16.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-24.1","spread":"14.65"},{"groupId":"OG001","value":"17.0","spread":"41.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.3","spread":"21.64"},{"groupId":"OG001","value":"10.2","spread":"54.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-21.6","spread":"13.36"},{"groupId":"OG001","value":"11.7","spread":"30.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-19.3","spread":"14.75"},{"groupId":"OG001","value":"5.4","spread":"28.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-11.0","spread":"25.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-12.5","spread":"22.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-9.4","spread":"26.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-12.6","spread":"28.45"}]}]}]},{"type":"SECONDARY","title":"Absolute Change in LDL-C From Baseline up to Day 720","description":"Absolute change in LDL-C from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-70.6","spread":"48.81"},{"groupId":"OG001","value":"16.5","spread":"44.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-66.1","spread":"61.85"},{"groupId":"OG001","value":"20.3","spread":"91.34"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-47.1","spread":"83.15"},{"groupId":"OG001","value":"-9.3","spread":"134.14"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-62.9","spread":"52.35"},{"groupId":"OG001","value":"11.8","spread":"69.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-50.8","spread":"44.65"},{"groupId":"OG001","value":"-4.3","spread":"69.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-36.6","spread":"75.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-46.8","spread":"73.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-41.9","spread":"92.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-39.8","spread":"96.59"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apo B From Baseline up to Day 720","description":"Percentage change in apolipoprotein B (Apo B) from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-20.3","spread":"12.92"},{"groupId":"OG001","value":"10.0","spread":"27.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-18.5","spread":"10.47"},{"groupId":"OG001","value":"4.5","spread":"17.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.8","spread":"10.11"},{"groupId":"OG001","value":"10.6","spread":"21.33"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-5.7","spread":"25.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-7.3","spread":"29.36"}]}]}]},{"type":"SECONDARY","title":"Absolute Change in Apo B From Baseline up to Day 720","description":"Absolute change in apolipoprotein B (Apo B) from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-37.3","spread":"33.35"},{"groupId":"OG001","value":"7.5","spread":"48.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-35.8","spread":"30.33"},{"groupId":"OG001","value":"0.3","spread":"35.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-28.7","spread":"27.16"},{"groupId":"OG001","value":"12.0","spread":"32.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-18.8","spread":"45.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-19.6","spread":"51.64"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Lp(a) From Baseline up to Day 720","description":"Percentage change in lipoprotein (a) \\[Lp(a)\\] from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.7","spread":"24.81"},{"groupId":"OG001","value":"-4.4","spread":"9.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.3","spread":"21.27"},{"groupId":"OG001","value":"-16.5","spread":"27.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.7","spread":"16.57"},{"groupId":"OG001","value":"-12.1","spread":"31.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-7.2","spread":"31.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-8.8","spread":"22.03"}]}]}]},{"type":"SECONDARY","title":"Absolute Change in Lp(a) From Baseline up to Day 720","description":"Absolute change in lipoprotein (a) \\[Lp(a)\\] from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.9","spread":"28.41"},{"groupId":"OG001","value":"-0.3","spread":"1.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.8","spread":"15.01"},{"groupId":"OG001","value":"5.3","spread":"15.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.8","spread":"7.03"},{"groupId":"OG001","value":"0.5","spread":"9.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3.0","spread":"14.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-0.3","spread":"9.12"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Non-HDL-C From Baseline up to Day 720","description":"Percentage change in non-high density lipoprotein cholesterol (non-HDL-C) from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-24.0","spread":"13.83"},{"groupId":"OG001","value":"19.0","spread":"43.34"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-23.3","spread":"10.99"},{"groupId":"OG001","value":"9.4","spread":"34.93"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-20.1","spread":"10.91"},{"groupId":"OG001","value":"7.1","spread":"24.38"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-11.8","spread":"25.33"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-13.0","spread":"23.65"}]}]}]},{"type":"SECONDARY","title":"Absolute Change in Non-HDL-C From Baseline up to Day 720","description":"Absolute change in non-high density lipoprotein cholesterol (non-HDL-C) from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-73.8","spread":"68.01"},{"groupId":"OG001","value":"28.8","spread":"94.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-74.4","spread":"57.63"},{"groupId":"OG001","value":"4.3","spread":"82.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-60.0","spread":"44.74"},{"groupId":"OG001","value":"6.0","spread":"56.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-51.4","spread":"81.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-45.8","spread":"89.10"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Total Cholesterol From Baseline up to Day 720","description":"Percentage change in total cholesterol from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-19.0","spread":"12.49"},{"groupId":"OG001","value":"16.0","spread":"37.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-19.1","spread":"10.30"},{"groupId":"OG001","value":"8.7","spread":"30.54"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.1","spread":"9.53"},{"groupId":"OG001","value":"6.8","spread":"21.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-9.3","spread":"20.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-9.6","spread":"20.86"}]}]}]},{"type":"SECONDARY","title":"Absolute Change in Total Cholesterol From Baseline up to Day 720","description":"Absolute change in total cholesterol from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-69.7","spread":"67.42"},{"groupId":"OG001","value":"29.5","spread":"99.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-71.4","spread":"56.65"},{"groupId":"OG001","value":"8.8","spread":"84.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-57.3","spread":"43.82"},{"groupId":"OG001","value":"10.0","spread":"59.14"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-46.5","spread":"80.87"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-40.4","spread":"88.44"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Triglycerides From Baseline up to Day 720","description":"Percentage change in triglycerides from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.3","spread":"31.92"},{"groupId":"OG001","value":"-15.7","spread":"5.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.6","spread":"30.66"},{"groupId":"OG001","value":"-5.8","spread":"31.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.4","spread":"24.72"},{"groupId":"OG001","value":"14.1","spread":"54.93"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"4.7","spread":"37.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"2.9","spread":"26.02"}]}]}]},{"type":"SECONDARY","title":"Absolute Change in Triglycerides From Baseline up to Day 720","description":"Absolute change in triglycerides from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.4","spread":"23.80"},{"groupId":"OG001","value":"-15.0","spread":"7.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.4","spread":"21.98"},{"groupId":"OG001","value":"-2.3","spread":"25.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.7","spread":"24.15"},{"groupId":"OG001","value":"28.0","spread":"72.23"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3.3","spread":"34.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3.9","spread":"27.40"}]}]}]},{"type":"SECONDARY","title":"Percent Change in HDL-C From Baseline up to Day 720","description":"Percentage change in high density lipoprotein cholesterol (HDL-C) from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.0","spread":"13.22"},{"groupId":"OG001","value":"-0.1","spread":"20.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.5","spread":"12.93"},{"groupId":"OG001","value":"10.9","spread":"12.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7","spread":"20.60"},{"groupId":"OG001","value":"9.2","spread":"21.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"12.3","spread":"17.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"13.9","spread":"18.81"}]}]}]},{"type":"SECONDARY","title":"Absolute Change in HDL-C From Baseline up to Day 720","description":"Absolute change in high density lipoprotein cholesterol (HDL-C) from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.1","spread":"5.18"},{"groupId":"OG001","value":"0.8","spread":"7.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.0","spread":"5.05"},{"groupId":"OG001","value":"4.5","spread":"5.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.7","spread":"7.75"},{"groupId":"OG001","value":"4.0","spread":"8.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"4.9","spread":"7.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"5.4","spread":"7.81"}]}]}]},{"type":"SECONDARY","title":"Percent Change in VLDL-C From Baseline up to Day 720","description":"Percentage change in very low density lipoprotein cholesterol (VLDL-C) from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.0","spread":"70.31"},{"groupId":"OG001","value":"74.5","spread":"108.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-29.0","spread":"49.96"},{"groupId":"OG001","value":"2.0","spread":"113.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.0","spread":"60.36"},{"groupId":"OG001","value":"34.6","spread":"56.37"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"9.5","spread":"98.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-1.4","spread":"69.03"}]}]}]},{"type":"SECONDARY","title":"Absolut Change in VLDL-C From Baseline up to Day 720","description":"Absolute change in very low density lipoprotein cholesterol (VLDL-C) from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.7","spread":"11.39"},{"groupId":"OG001","value":"8.5","spread":"20.37"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.6","spread":"11.71"},{"groupId":"OG001","value":"-7.5","spread":"18.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.2","spread":"17.89"},{"groupId":"OG001","value":"10.3","spread":"21.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-4.6","spread":"18.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-6.0","spread":"18.81"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Apo A1 From Baseline up to Day 720","description":"Percentage change in apolipoprotein A1 (Apo A1) from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.9","spread":"10.72"},{"groupId":"OG001","value":"-1.3","spread":"2.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.1","spread":"10.87"},{"groupId":"OG001","value":"9.0","spread":"7.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.1","spread":"16.49"},{"groupId":"OG001","value":"13.7","spread":"12.99"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"12.8","spread":"12.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"6.5","spread":"10.10"}]}]}]},{"type":"SECONDARY","title":"Absolute Change in Apo A1 From Baseline up to Day 720","description":"Absolute change in apolipoprotein A1 (Apo A1) from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.2","spread":"14.10"},{"groupId":"OG001","value":"-1.3","spread":"2.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.7","spread":"13.47"},{"groupId":"OG001","value":"10.3","spread":"7.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.2","spread":"18.82"},{"groupId":"OG001","value":"16.0","spread":"14.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"14.9","spread":"13.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"7.4","spread":"12.40"}]}]}]},{"type":"SECONDARY","title":"Percent Change in PCSK9 From Baseline up to Day 720","description":"Percentage change in proprotein convertase subtilisin/kexin type 9 (PCSK9) from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-56.8","spread":"13.73"},{"groupId":"OG001","value":"-17.3","spread":"14.77"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-60.4","spread":"12.62"},{"groupId":"OG001","value":"-1.7","spread":"11.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-65.3","spread":"12.51"},{"groupId":"OG001","value":"-5.1","spread":"19.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-59.7","spread":"9.05"},{"groupId":"OG001","value":"-2.8","spread":"22.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-68.1","spread":"10.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-64.1","spread":"12.12"}]}]}]},{"type":"SECONDARY","title":"Absolut Change in PCSK9 From Baseline up to Day 720","description":"Absolute change in proprotein convertase subtilisin/kexin type 9 (PCSK9) from baseline to each assessment time up to Day 720.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-278.7","spread":"113.31"},{"groupId":"OG001","value":"-98.5","spread":"87.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-296.3","spread":"118.18"},{"groupId":"OG001","value":"-6.1","spread":"64.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-323.1","spread":"129.32"},{"groupId":"OG001","value":"-35.3","spread":"100.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-292.6","spread":"100.44"},{"groupId":"OG001","value":"-14.0","spread":"127.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-347.3","spread":"106.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-327.7","spread":"110.4"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":9},"commonTop":["COVID-19","Abdominal pain upper","Influenza like illness","Injection site erythema","Injection site reaction"]}}}